Open AccessEfficacy and Safety of Fecal Microbiota Transplant for recurrent Clostridium Difficile Infection in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
Author(s) -
Cheng Fang,
Zhong Huang,
Zhi Li,
Wei Wei
Publication year - 2022
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2022.8814/2022
Subject(s) - medicine , clostridium difficile , meta analysis , inflammatory bowel disease , ulcerative colitis , adverse effect , gastroenterology , refractory (planetary science) , subgroup analysis , disease , fecal bacteriotherapy , surgery , antibiotics , physics , astrobiology , microbiology and biotechnology , biology
the objective of this systematic review and meta-analysis was to evaluate the outcomes of fecal microbiota transplantation (FMT) therapy for recurrent Clostridium difficile infection (CDI) in inflammatory bowel disease (IBD) patients.